Groupe Bioclinic
FranceEntry
2019
Hold
3yr
Exit
2022
Who owns Groupe Bioclinic?
Groupe Bioclinic was owned by Socadif through SOCADIF (1991 vintage) from 2019 to 2022, exited via Trade Sale. Across its history, Groupe Bioclinic has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-05-07
Key takeaways
- ·Fully exited in 2022.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2022 to .
More from SOCADIF
Other portfolio companies in the same fund.
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
UK
US
Track Groupe Bioclinic
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Groupe Bioclinic?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Groupe Bioclinic.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue